[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Wednesday 27 October 2021
Salford GP Header Montage
Latest News:
RSS icon
Medicine, tablets, pills


This is an electronic version of our Formulary written in conjunction with the Medicine Management Committee and the Pharmacy department.   The purpose of the Formulary is:

  • To promote safe, rational and cost effective prescribing within the Trust.
  • To help select the most appropriate drug amongst the many available.


This formulary is intended to act as a rapid reference source.  It is intended for the guidance of medical practitioners, nurses and other healthcare workers.


For local GPs and Non-medical prescribers working in the community there is the Greater Manchester Joint Formulary produced by the Greater Manchester Medicines Management Group (GMMMG).  The formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. All medicines recommended for use in the NHS in a NICE Technology Assessment (TA) are approved for use in Greater Manchester, the GMMMG site provides a list of medicines with a positive recommendation from  NICE and provides links to these TAs in the GMMMG formulary.  In the SRFT formulary below all the drugs with a positive NICE TA that are applicable to SRFT are included in the formulary.


How to use

All medicines are listed alphabetically using the generic name where possible.  Some brand names are used.


  1. Type the drug name in the 'Keywords' box

  2. Click on the 'Search' button

  3. Within the results, click on the 'generic name' of the medicine you are looking for.

  4. Click on the 'Link' - this will take you to further information that talks about that medicine. 



Drug NameBNF CategoryComment / Usage RestrictionsDetails
Tanganil acetyl-DL-leucine 500mg tablets See online BNFTo treat patients with Ataxia of different aetiologies, including Niemann Pick type C. Approved March 2016 as per proposed indication. CCG funding to be sought ahead of treatment.  
Taptiqom11.5 - Glaucoma and ocular hypertension Eye drops, tafluprost 15 micrograms, timolol (as maleate) 5 mg/mL, Approved MMG 19/12/16. Approved for 2nd/3rd line use under Ophthalmic consultant request only.  
Teicoplanin5.1.7 Some other antibacterialsPlease see restricted use antibiotic policy. Suitable for use by the Home IV team  
Temazepam15.1.4.1 Anxiolytics and neuroleptics  
Temazepam4.1.1 Hypnotics1st choice hypnotic 
Temocillin5.1.1.2 Penicillinase-resistant penicillinsOn the recommendation of microbiologist following sensitivities for complicated UTI 
Temozolomide8.1.5 Other antineoplastic drugsAvailble if requested - please contact pharmacy. For use in line with NICE guidance by neurosurgery team only. 
Tenecteplase2.10.2 Fibrinolytic drugsIn line with NICE guidance when used for myocardial infarction. Tenecteplase is the agent of choice at SRFT (approved MMG Nov 2001). 
Tenofovir5.3 Antiviral drugsFor use by consultant Gastroenterologist / Hepatologist in line with NICE guidance for treatment of patients with chronic hepatitis B. Service only commenced Sept 2011 after MMG approval 
Terbinafine5.2 Antifungal drugsDermatology only 


All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.